Veradermics is a verifiable, high-value clinical-stage biopharmaceutical company (Ticker: MANE) actively pursuing an IPO with a valuation ~$500M. The company has raised over $250M (including a $150M Series C) to develop VDPHL01, an extended-release oral minoxidil for hair loss. While the project itself possesses exceptional real-world utility, market timing, and verified traction (Phase 3 trials), the submission quality is critically poor, containing false data (e.g., 'Team Size: 0', 'most people have used my product'). The score reflects the immense value of the verified entity, penalized slightly for the low-effort submission.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline